Unexpectedly,
rosiglitazone increased the risk of heart attacks.
Furthermore,
rosiglitazone increased mortality in those with type 2 diabetes [34].
Not exact matches
The researchers showed that the type 2 diabetes drug
rosiglitazone, which
increases insulin sensitivity, also protects neurons from ADDLs.
The diabetes drug
rosiglitazone has been under intense scrutiny since a 2007 study in the New England Journal of Medicine looked at more than 40 clinical trials and linked the drug's use with
increased risk of heart attack and death from heart disease.